CONMED Corporation (NYSE: CNMD) has reported an uptick in its share price, closing at USD 46.52 with a daily increase of 0.62 points, or 1.35%. This development provides investors with insight into the company’s current market valuation and trading momentum.
In this article:
- Company Overview
- Stock Performance
- Market Position and Sector
- Governance and Leadership
- Key Financial Data
- FAQ
- Conclusion
- Disclaimer
- Official Source
Company Overview
CONMED Corporation is a medical technology company headquartered in Largo, Florida. Incorporated in 1970, the firm designs, manufactures, and markets surgical devices and related equipment used by healthcare institutions worldwide. Its portfolio includes orthopedic surgery products such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These offerings enable orthopedic surgeons to address soft tissue repair and perform minimally invasive sports medicine procedures. The company also develops general surgery and endoscopic products for gastroenterology, along with cardiac monitoring devices.
Products are marketed under well-recognized brands including Hall, CONMED Linvatec, Concept, and Shutt. Distribution channels include direct sales to hospitals, surgery centers, specialty providers, and through specialized medical distributors.
Stock Performance
Shares of CONMED currently trade at USD 46.52, representing a daily gain of 1.35%. The market capitalization stands at approximately USD 1.44 billion, reflecting total equity value based on outstanding shares. This figure is important for assessing the firm’s size and valuation relative to peers in the medical devices industry. The stock has moved within a 52-week range of USD 45.07 to USD 78, indicating recent volatility levels in price performance.
Trading volume reached 203,296 shares during the latest session, below the average volume of 449,709 shares, signalling relatively lighter investor activity compared to historical patterns.
Market Position and Sector
Operating within the healthcare sector and classified under the medical devices industry, CONMED competes with other surgical device manufacturers across global markets. Its diversified product portfolio allows for participation in both orthopedic and general surgery markets, as well as endoscopic and cardiac monitoring channels. This positioning supports stable demand driven by global healthcare procedures and elective surgeries.
Industry peers focus on innovation, regulatory compliance, and distribution efficiency, factors which directly influence market share. CONMED’s long-standing industry presence and brand recognition reinforce its competitiveness.
Governance and Leadership
The company is led by CEO Patrick J. Beyer. Effective governance in regulated healthcare markets requires strategic oversight and adherence to both domestic and international medical standards. Leadership capability impacts decision-making in research development, manufacturing processes, and global distribution strategies.
Key Financial Data
Important metrics for investors include:
- Share Price: USD 46.52
- Market Capitalization: USD 1.44 billion
- Dividend: Last paid USD 0.80, reflecting shareholder return policies
- 52-Week Range: USD 45.07 to USD 78
- Volume: 203,296 (Average 449,709)
- Exchange: NYSE – New York Stock Exchange
- ISIN: US2074101013
- CUSIP: 207410101
FAQ
- Does CONMED pay dividends? Yes. The last dividend was USD 0.80.
- Where is CONMED traded? On the New York Stock Exchange, symbol CNMD.
- How many employees does CONMED have? Approximately 3,900 full-time employees.
- What is the company’s market cap? Around USD 1.44 billion.
Conclusion
CONMED’s current stock performance reflects moderate gains and stable market capitalization within its industry. Investors may see the company’s balance between innovation, established brand portfolio, and consistent dividend policy as part of its long-term value proposition.
Disclaimer
This article is for informational purposes only. It does not constitute financial advice or a recommendation to buy or sell any security.
Official Source
For full information about the company, see the link below.